Company Overview of Apollo Biosciences, Inc.
Apollo Biosciences, Inc. engages in the research and development, and commercialization of drug delivery platform for cancer treatment. It offers Pharmefex + doxorubicin for treatment of mesothelioma; Pharmefex + dacarbazine for treatment of melanoma; and solutions for the delivery of small interfering RNA and short hairpin RNA. Apollo Biosciences, Inc. has a strategic partnership with Vermont Center for Emerging Technologies. The company is based in Burlington, Vermont.
Key Executives for Apollo Biosciences, Inc.
Similar Private Companies By Industry
|Oligos Etc., Inc.||United States|
|Kolltan Pharmaceuticals, Inc.||United States|
|Calypte Biomedical Corp.||United States|
|Kyto BioPharma Inc.||United States|
|BEAT BioTherapeutics Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Apollo Biosciences, Inc., please visit www.apollobio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.